Financial Snapshot

Revenue
$20.43M
TTM
Gross Margin
93.84%
TTM
Net Earnings
-$3.496M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
14.35%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$53.78M
Q3 2024
Cash
Q3 2024
P/E
-0.4293
Nov 29, 2024 EST
Free Cash Flow
-$1.754M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $29.60M $18.39M $20.61M $23.17M $22.75M $16.46M $128.5K $85.10K $100.1K $135.1K $130.9K $120.0K $750.0K $640.0K $700.0K $770.0K $240.0K $0.00 $0.00 $0.00 $10.00K $10.00K $10.00K $10.00K $20.00K $20.00K
YoY Change 60.94% -10.77% -11.04% 1.82% 38.23% 12708.56% 51.0% -14.99% -25.91% 3.21% 9.08% -84.0% 17.19% -8.57% -9.09% 220.83% -100.0% 0.0% 0.0% 0.0% -50.0% 0.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $29.60M $18.39M $20.61M $23.17M $22.75M $16.46M $128.5K $85.10K $100.1K $135.1K $130.9K $120.0K $750.0K $640.0K $700.0K $770.0K $240.0K $0.00 $0.00 $0.00 $10.00K $10.00K $10.00K $10.00K $20.00K $20.00K
Cost Of Revenue $1.342M $2.588M $3.312M $2.248M $1.094M $827.4K $53.50K $5.500K $4.900K $73.00K $140.0K $130.0K $150.0K $140.0K $130.0K $160.0K $170.0K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $0.00
Gross Profit $28.26M $15.80M $17.30M $20.92M $21.66M $488.1K $75.00K $79.60K $95.20K $62.10K -$10.00K -$20.00K $600.0K $500.0K $570.0K $610.0K $70.00K $0.00 $0.00 $10.00K $10.00K $10.00K $10.00K $20.00K $10.00K
Gross Profit Margin 95.47% 85.93% 83.93% 90.3% 95.19% 2.97% 58.37% 93.54% 95.1% 45.97% -7.64% -16.67% 80.0% 78.13% 81.43% 79.22% 29.17% 100.0% 100.0% 100.0% 100.0% 100.0% 50.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $23.53M $20.66M $19.32M $18.54M $23.99M $22.20M $5.818M $3.052M $1.968M $2.424M $2.902M $3.935M $5.500M $5.890M $4.800M $3.990M $1.900M $420.0K $30.00K $260.0K $150.0K $20.00K $20.00K $20.00K $20.00K $20.00K
YoY Change 13.86% 6.97% 4.17% -22.7% 8.06% 281.56% 90.6% 55.11% -18.83% -16.45% -26.27% -28.45% -6.62% 22.71% 20.3% 110.0% 352.38% 1300.0% -88.46% 73.33% 650.0% 0.0% 0.0% 0.0% 0.0%
% of Gross Profit 83.26% 130.76% 111.67% 88.64% 110.75% 4547.63% 7756.67% 3834.42% 2067.02% 3903.7% 916.67% 1178.0% 842.11% 654.1% 2714.29% 1500.0% 200.0% 200.0% 200.0% 100.0% 200.0%
Research & Development $1.189M $1.725M $4.110M $2.408M $2.183M $1.378M $1.361M $794.2K $783.8K $1.455M $1.290M $850.0K $920.0K $1.120M $2.140M $2.100M $1.440M $0.00
YoY Change -31.07% -58.03% 70.68% 10.31% 58.48% 1.2% 71.38% 1.33% -46.12% 12.77% 51.76% -7.61% -17.86% -47.66% 1.9% 45.83%
% of Gross Profit 4.21% 10.92% 23.76% 11.51% 10.08% 282.22% 1814.8% 997.74% 823.32% 2342.51% 153.33% 224.0% 375.44% 344.26% 2057.14%
Depreciation & Amortization $32.00K $53.00K $59.00K $60.00K $73.00K $61.00K $48.70K $7.200K $7.600K $10.30K $13.00K $18.80K $10.00K $10.00K $10.00K $10.00K $20.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -39.62% -10.17% -1.67% -17.81% 19.67% 25.26% 576.39% -5.26% -26.21% -20.77% -30.85% 88.0% 0.0% 0.0% 0.0% -50.0%
% of Gross Profit 0.11% 0.34% 0.34% 0.29% 0.34% 12.5% 64.93% 9.05% 7.98% 16.59% 1.67% 2.0% 1.75% 1.64% 28.57% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Operating Expenses $24.72M $22.39M $4.110M $2.408M $26.17M $23.92M $7.179M $3.846M $2.752M $3.952M $4.332M $4.921M $6.420M $7.010M $6.940M $6.090M $3.340M $420.0K $30.00K $260.0K $150.0K $20.00K $20.00K $10.00K $20.00K $20.00K
YoY Change 10.39% 444.72% 70.68% -90.8% 9.41% 233.21% 86.63% 39.79% -30.37% -8.76% -11.98% -23.35% -8.42% 1.01% 13.96% 82.34% 695.24% 1300.0% -88.46% 73.33% 650.0% 0.0% 100.0% -50.0% 0.0%
Operating Profit $3.540M -$6.586M -$6.128M -$32.00K -$4.512M -$8.454M -$7.104M -$3.767M -$2.656M -$3.817M -$4.201M -$4.806M -$5.820M -$6.510M -$6.370M -$5.480M -$3.270M -$420.0K -$260.0K -$140.0K -$10.00K -$10.00K $0.00 $0.00 -$10.00K
YoY Change -153.75% 7.47% 19050.0% -99.29% -46.63% 19.01% 88.58% 41.8% -30.4% -9.14% -12.59% -17.42% -10.6% 2.2% 16.24% 67.58% 678.57% 85.71% 1300.0% 0.0% -100.0% -100.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense $7.383M $5.013M $3.101M $5.989M $27.63M $22.80M -$6.600K -$2.756M -$94.60K -$11.70K -$1.288M -$4.123M -$740.0K -$360.0K -$1.730M $100.0K -$120.0K -$20.00K -$30.00K -$10.00K $0.00 $0.00 $0.00 $0.00 -$10.00K -$10.00K
YoY Change 47.28% 61.66% -48.22% -78.32% 21.18% -345493.94% -99.76% 2813.42% 708.55% -99.09% -68.76% 457.19% 105.56% -79.19% -1830.0% -183.33% 500.0% -33.33% 200.0% -100.0% 0.0%
% of Operating Profit 208.56% -91625968981333400.0%
Other Income/Expense, Net $681.0K $680.0K $761.0K $2.303M -$3.109M $0.00 $286.7K $0.00 $1.162M -$6.687M $1.892M -$330.0K -$210.0K -$90.00K $0.00 $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 0.15% -10.64% -66.96% -174.08% -100.0% -100.0% -117.38% -453.51% -673.18% 57.14% 133.33% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$3.792M -$10.57M -$15.92M $973.0K -$54.68M -$72.55M -$7.110M -$5.939M -$3.381M -$2.655M -$10.89M -$2.914M -$8.870M -$8.170M -$8.520M -$5.370M -$3.280M -$440.0K -$20.00K -$270.0K -$140.0K -$10.00K -$10.00K -$10.00K -$20.00K -$10.00K
YoY Change -64.11% -33.64% -1736.28% -101.78% -24.63% 920.34% 19.72% 75.66% 27.35% -75.61% 273.57% -67.14% 8.57% -4.11% 58.66% 63.72% 645.45% 2100.0% -92.59% 92.86% 1300.0% 0.0% 0.0% -50.0% 100.0%
Income Tax -$59.00K $60.00K $25.00K -$381.0K $164.0K $39.00K $2.600K $2.000K $5.000K $5.200K $800.00 $1.900K $0.00 $0.00 $10.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income -39.16%
Net Earnings -$3.700M -$10.60M -$15.90M $1.354M -$54.80M -$72.59M -$7.113M -$5.941M -$3.379M -$2.663M -$10.91M -$3.407M -$8.870M -$8.170M -$8.520M -$5.370M -$3.280M -$440.0K -$20.00K -$270.0K -$140.0K -$10.00K -$10.00K -$10.00K -$20.00K -$10.00K
YoY Change -65.09% -33.33% -1274.3% -102.47% -24.5% 920.51% 19.73% 75.8% 26.91% -75.59% 220.17% -61.59% 8.57% -4.11% 58.66% 63.72% 645.45% 2100.0% -92.59% 92.86% 1300.0% 0.0% 0.0% -50.0% 100.0%
Net Earnings / Revenue -12.5% -57.64% -77.15% 5.84% -240.86% -441.02% -5535.25% -6981.08% -3376.02% -1970.98% -8332.62% -2839.0% -1182.67% -1276.56% -1217.14% -697.4% -1366.67% -1400.0% -100.0% -100.0% -100.0% -100.0% -50.0%
Basic Earnings Per Share -$0.07 -$0.21 -$0.32 -$0.14 -$1.81
Diluted Earnings Per Share -$0.07 -$0.21 -$323.8K $27.69K -$1.298M -$11.08M -$15.15M -$55.53M -$39.83M -$32.17M -$0.14 -$1.81 -$5.693B -$5.629B -$11.05B -$7.642B -$6.291B -$89.84B -$5.793B -$96.88B -$116.4B -$10.23B -$9.391B -$7.575B -$18.77B -$9.122B

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $2.547M $2.021M $2.279M $2.487M $29.70M $3.255M $5.449M $318.2K $432.1K $1.241M $1.270M $10.00K $90.00K $60.00K $990.0K $2.000M $5.790M $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 26.03% -11.32% -8.36% -91.63% 812.47% -40.27% 1612.45% -26.36% -65.17% -2.31% 12600.0% -88.89% 50.0% -93.94% -50.5% -65.46% 5163.64%
Cash & Equivalents
Short-Term Investments $0.00 $27.93M
Other Short-Term Assets $1.727M $1.514M $1.380M $1.485M $1.402M $192.6K $79.20K $78.60K $104.3K $58.20K $60.00K $60.00K $170.0K $80.00K $90.00K $190.0K $160.0K
YoY Change 14.07% 9.71% -7.07% 5.92% 627.93% 143.18% 0.76% -24.64% 79.21% -3.0% 0.0% -64.71% 112.5% -11.11% -52.63% 18.75%
Inventory $1.711M $2.379M $4.392M $7.087M $7.971M $0.00 $0.00 $0.00 $10.00K $10.00K
Prepaid Expenses
Receivables $5.524M $375.0K $1.040M $198.0K $2.150M $63.30K $6.500K $5.100K $11.80K $9.300K $30.00K $10.00K $50.00K $50.00K $60.00K $100.0K $60.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $159.5K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $11.51M $6.289M $9.091M $11.26M $41.22M $3.511M $5.694M $401.9K $548.2K $1.308M $1.360M $80.00K $320.0K $200.0K $1.140M $2.280M $6.010M $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $10.00K
YoY Change 83.0% -30.82% -19.24% -72.69% 1074.19% -38.35% 1316.82% -26.69% -58.09% -3.82% 1600.0% -75.0% 60.0% -82.46% -50.0% -62.06% 5363.64% -100.0% 0.0% 0.0%
Property, Plant & Equipment $2.396M $2.874M $3.632M $4.192M $4.625M $110.8K $120.7K $9.500K $1.700K $8.700K $20.00K $20.00K $30.00K $20.00K $20.00K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -16.63% -20.87% -13.36% -9.36% 4074.19% -8.2% 1170.53% 458.82% -80.46% -56.5% 0.0% -33.33% 50.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.98M $38.80M $43.72M $43.79M $13.33M $0.00 $195.9K
YoY Change -45.93% -11.25% -0.17% 228.64% -100.0%
Other Assets $296.0K $263.0K $295.0K $296.0K $285.0K $27.10K $25.10K $13.60K $4.100K $19.30K $20.00K $20.00K $10.00K $20.00K $20.00K $30.00K $0.00
YoY Change 12.55% -10.85% -0.34% 3.86% 951.66% 7.97% 84.56% 231.71% -78.76% -3.5% 0.0% 100.0% -50.0% 0.0% -33.33%
Total Long-Term Assets $23.67M $41.94M $47.64M $48.28M $18.24M $1.641M $401.9K $110.2K $18.90K $28.00K $40.00K $50.00K $50.00K $40.00K $20.00K $350.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -43.56% -11.98% -1.32% 164.76% 1011.08% 308.36% 264.7% 483.07% -32.5% -30.0% -20.0% 0.0% 25.0% 100.0% -94.29%
Total Assets $35.18M $48.23M $56.73M $59.54M $59.46M $5.152M $6.096M $512.1K $567.1K $1.336M $1.400M $130.0K $370.0K $240.0K $1.160M $2.630M $6.010M $110.0K $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $10.00K $10.00K
YoY Change
Accounts Payable $5.887M $3.785M $2.583M $2.023M $7.277M $346.9K $736.9K $426.6K $852.0K $868.9K $2.490M $3.090M $1.780M $1.380M $1.290M $340.0K $220.0K $10.00K $10.00K $10.00K $10.00K $0.00
YoY Change 55.54% 46.54% 27.68% -72.2% 1997.72% -52.92% 72.74% -49.93% -1.94% -65.1% -19.42% 73.6% 28.99% 6.98% 279.41% 54.55% 0.0% 0.0% 0.0%
Accrued Expenses $12.70M $10.47M $7.346M $6.580M $5.212M $657.5K $729.7K $1.011M $800.9K $370.8K $790.0K $1.910M $650.0K $600.0K $640.0K $720.0K $320.0K $330.0K $210.0K $200.0K $10.00K $0.00 $0.00 $30.00K
YoY Change 21.36% 42.49% 11.64% 26.25% 692.7% -9.89% -27.79% 26.17% 115.99% -53.06% -58.64% 193.85% 8.33% -6.25% -11.11% 125.0% -3.03% 57.14% 5.0% 1900.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $3.573M $5.615M $8.707M $934.0K $793.0K $0.00 $0.00 $0.00 $0.00 $1.476M $0.00 $7.390M $4.260M $0.00 $0.00 $50.00K $50.00K $0.00 $110.0K $90.00K $20.00K $10.00K $10.00K $0.00 $0.00 $0.00
YoY Change -36.37% -35.51% 832.23% 17.78% -100.0% -100.0% 73.47% -100.0% 0.0% -100.0% 22.22% 350.0% 100.0% 0.0%
Long-Term Debt Due $24.60M $21.47M $12.56M $10.07M $13.76M $1.300K $32.80K $57.50K $2.400K $3.500K $10.00K $10.00K $10.00K $30.00K $100.0K $90.00K $0.00
YoY Change 14.57% 70.97% 24.72% -26.83% 1058284.62% -96.04% -42.96% 2295.83% -31.43% -65.0% 0.0% 0.0% -66.67% -70.0% 11.11%
Total Short-Term Liabilities $61.51M $54.32M $37.10M $23.38M $32.83M $1.165M $1.545M $1.541M $1.701M $3.095M $3.560M $13.20M $11.78M $4.440M $2.240M $1.460M $660.0K $330.0K $310.0K $290.0K $30.00K $20.00K $20.00K $10.00K $10.00K $30.00K
YoY Change 13.22% 46.42% 58.67% -28.77% 2716.8% -24.58% 0.31% -9.45% -45.04% -13.06% -73.03% 12.05% 165.32% 98.21% 53.42% 121.21% 100.0% 6.45% 6.9% 866.67% 50.0% 0.0% 100.0% 0.0% -66.67%
Long-Term Debt $2.226M $3.726M $4.650M $3.372M $0.00 $589.8K $3.400K $36.10K $2.766M $2.500K $10.00K $10.00K $10.00K $0.00 $30.00K $130.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K
YoY Change -40.26% -19.87% 37.9% -100.0% 17247.06% -90.58% -98.69% 110532.0% -75.0% 0.0% 0.0% -100.0% -76.92% -100.0%
Other Long-Term Liabilities $19.20M $24.27M $36.43M $37.94M $37.68M $110.1K $936.6K
YoY Change -20.87% -33.39% -3.97% 0.68% 34125.25%
Total Long-Term Liabilities $21.43M $27.99M $41.08M $41.31M $37.68M $699.9K $3.400K $36.10K $3.702M $2.500K $10.00K $10.00K $10.00K $0.00 $30.00K $130.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K
YoY Change -23.45% -31.86% -0.55% 9.63% 5283.91% 20485.29% -90.58% -99.02% 147996.0% -75.0% 0.0% 0.0% -100.0% -76.92% -100.0%
Total Liabilities $82.94M $82.32M $78.18M $64.69M $70.51M $1.131M $1.549M $1.577M $5.404M $3.098M $3.560M $13.20M $11.79M $4.440M $2.270M $1.580M $660.0K $330.0K $310.0K $290.0K $30.00K $20.00K $20.00K $10.00K $10.00K $130.0K
YoY Change 0.75% 5.28% 20.85% -8.25% 6134.77% -26.98% -1.77% -70.82% 74.44% -12.99% -73.03% 11.96% 165.54% 95.59% 43.67% 139.39% 100.0% 6.45% 6.9% 866.67% 50.0% 0.0% 100.0% 0.0% -92.31%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding 53.11M 49.44M 49.25M 48.90M 42.26M 36.86M 75.80M shares 1.888M shares
Diluted Shares Outstanding 53.11M 49.44M 49.25M 75.80M shares 1.888M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.5008 Million

About Emmaus Life Sciences, Inc.

Emmaus Life Sciences, Inc. operates as a biopharmaceutical company. The company is headquartered in Torrance, California and currently employs 51 full-time employees. The company went IPO on 2000-05-09. The firm is engaged in the discovery, development, marketing and sale of treatments and therapies, primarily for rare and orphan diseases. Its lead product, Endari (prescription grade L-glutamine oral powder) helps to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Its product pipeline includes ELS001/ELS007, ELS004, ELS005, ELS003, and ELS002. The Company, through Kainos Medicine, Inc. (Kainos), has a license in the territory encompassing the United States, the United Kingdom, and the European Union to patent rights, know-how, and other intellectual property relating to Kainos’s IRAK4 inhibitor, referred to as KM10544, for the treatment of cancers, including leukemia, lymphoma, and solid tumor cancers. The firm has also developed chondrocyte and osteoblast cell sheets using human mesenchymal stem cells.

Industry: Pharmaceutical Preparations Peers: CLS Holdings USA, Inc. ADIAL PHARMACEUTICALS, INC. ARTELO BIOSCIENCES, INC. CNS Pharmaceuticals, Inc. GB SCIENCES INC JOHNSON & JOHNSON RANGE IMPACT, INC. PALISADE BIO, INC.